You’re in the
Right Place
We are the organization working to cure Rett Syndrome. As the largest worldwide funder of Rett research, we're advancing genetic medicines that target the root cause of Rett. The gene therapy programs currently in clinical trials were started and incubated at RSRT. We are the go-to partner for genetic medicine scientists and companies.
The commitment and passion of Rett families in the US and around the globe make our critical work possible. If you want a cure as urgently as we do, we welcome you to our site and invite you to join us in our quest.
Rare diseases don’t cure themselves. Developing genetic medicines is a complex, expensive effort with many moving parts. We are the organization orchestrating this global effort. Here is our plan to cure Rett syndrome.
Our goal is to put ourselves out of business as quickly as possible.
Recently Diagnosed?
Getting a Rett syndrome diagnosis is one of the hardest things you’ll ever face. We know this first-hand. Emotions can run the gamut and it can all seem overwhelming. You’re worried about your child and your family. You’re reading everything you can get your hands on but unsure how to interpret it or if it's relevant. We’ve been there, just reach out to us: we’ve got your back.
Meet Omar and Jonathan
Omar Abuddayeh, PhD and Jonathan Gootenberg, PhD met while studying at MIT and took the unconventional path of joining forces to set up the AbuGoot Lab at Harvard Medical School. These Genetic Engineers are developing the technology that could potentially address all Rett mutations by “rewriting” the RNA sequence.
Latest News
Make a Stand for Rett Syndrome!
Summer is here and we’ve got a family friendly activity to raise money to accelerate cures Rett syndrome. We've got some great resources to help you get set up quickly and easily, just click the link below to learn more.
Take Action
MECP2 Duplication
MECP2 Duplication syndrome (MDS) is caused by a genetic error that duplicates a section of the X chromosome that includes the MECP2 gene. The MECP2 Duplication Syndrome Fund at RSRT, created in 2010, puts the intellectual and scientific resources of RSRT immediately to work for the MDS community.
Rett Syndrome Genetic Medicines Summit 2023
In 2023 we hosted the first meeting of its kind with biopharma companies front and center. The Summit gathered basic scientists, pre-clinical, clinical, and regulatory experts to foster discussion, refine expectations, and identify best practices to expedite genetic medicine development.
